Pharmaceutical Distribution Channel in Bangladesh
Research on Pharmaceutical Channel Distribution
2013
Medhad Nasser Chowdhury
082735530
4/30/2013
MKT 450.1
Faculty Members: Shahed Hussain
The New Era
A journey through the pharmaceutical channel system in Bangladesh
Abstract The aim of the study is to analyze the changes that took place in Bangladesh Pharmaceutical Industries Channel system in the past decade. The current scenario of the pharmaceutical Industry in Bangladesh and external effects that might bring in further changes in the industry is to be thoroughly looked at. Countries with similar channel structure are also analyzed in this course of study. Countries such as Japan, India and Myanmar are presented with their issues and successes. The Rapid growth of the Bangladesh pharmaceutical industry gave birth to many scopes in creation of different forms of Channel Intermediaries such as wholesalers, retailers out sourced salesperson, and manufacturer sales reps. The pharmaceutical industry developed rapidly from the 1980s after the introduction of Drug (Control) Ordinance-1982. Adequate infrastructure and use of trained manpower were two essential requisites for implementation of national pharmaceutical policies in Bangladesh. The country was importing significant amount of medicine and also raw materials for the industry from abroad. But the industry has started to export its products in foreign market, especially in the Middle East and Europe with great success. This study tries to identify the similarities and dissimilarities between the Bangladeshi pharmaceutical Industry and the Pharmaceutical Industries in neighboring countries where the industry infrastructure not too far from Bangladesh’s.
Introduction
The pharmaceutical sector is one of the thrust sectors in Bangladesh. Before Liberation, there was hardly any pharmaceutical enterprise in Bangladesh (then East Pakistan). After several years of liberation, the government could not increase (in relative terms)
2013
Medhad Nasser Chowdhury
082735530
4/30/2013
MKT 450.1
Faculty Members: Shahed Hussain
The New Era
A journey through the pharmaceutical channel system in Bangladesh
Abstract The aim of the study is to analyze the changes that took place in Bangladesh Pharmaceutical Industries Channel system in the past decade. The current scenario of the pharmaceutical Industry in Bangladesh and external effects that might bring in further changes in the industry is to be thoroughly looked at. Countries with similar channel structure are also analyzed in this course of study. Countries such as Japan, India and Myanmar are presented with their issues and successes. The Rapid growth of the Bangladesh pharmaceutical industry gave birth to many scopes in creation of different forms of Channel Intermediaries such as wholesalers, retailers out sourced salesperson, and manufacturer sales reps. The pharmaceutical industry developed rapidly from the 1980s after the introduction of Drug (Control) Ordinance-1982. Adequate infrastructure and use of trained manpower were two essential requisites for implementation of national pharmaceutical policies in Bangladesh. The country was importing significant amount of medicine and also raw materials for the industry from abroad. But the industry has started to export its products in foreign market, especially in the Middle East and Europe with great success. This study tries to identify the similarities and dissimilarities between the Bangladeshi pharmaceutical Industry and the Pharmaceutical Industries in neighboring countries where the industry infrastructure not too far from Bangladesh’s.
Introduction
The pharmaceutical sector is one of the thrust sectors in Bangladesh. Before Liberation, there was hardly any pharmaceutical enterprise in Bangladesh (then East Pakistan). After several years of liberation, the government could not increase (in relative terms)
References: * Abbott T. A. (1995), “Price regulation in the pharmaceutical industry: Prescription or * placebo?” Journal of Health Economics, Volume 14, Issue 5, December 1995, * Braithwaite J. (January, 1993), “Transnational Regulation of the Pharmaceutical * Industry” Annals of the American Academy of Political and Social Science, Vol * Grace C. (June, 2004), “The Effect of Changing Intellectual Property on Pharmaceutical * Industry Prospects in India and China: Considerations for Access to * Griffin R.W., Pustay M.W. (2001), “International Business: A Managerial Perspective” * Third Edition, Pearson Education, Inc * http://banglapedia.search.com.bd/HT/P_0154.htm (Retrieved on: December 03, 2009). * http://www.pharmadu.net/bps/companyinfo.htm (Retrieved on: December 10, 2009) * Humer F.B. (16 March, 2005), “Innovation in the Pharmaceutical Industry —Future * Prospects” Talk by Dr Franz B * Jayasuriya D. C. (December, 1991), “Pharmaceuticals and Developing Countries: * Problems and Prospects” Pharmacy World & Science, Springer Netherlands, * Volume 13, Number 6/, 1991, pp. 244-247. * Kotler P * Rugman A.M. & Hodgetts R.M. (2004), “International Business” Third Edition, Pearson * Education (Singapore) Pte * Shariat Ullah M., Razzak B.M., (2006), “Problems and Prospects of Pharmaceutical * Industry in Bangladesh” Journal of Business and Technology, Vol * January- June, 2006, pp. 35-44. * Skinner S.J., Ivancevich J.M * Smith S.E. (May, 2000), “Opening Up to the World: India’s Pharmaceutical Companies * Prepare for 2005” Asia/Pacific Research Center, Institute for International